These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20484480)

  • 1. Cardiovascular risk, cardiac function, physical activity, and quality of life with and without long-term growth hormone therapy in adult survivors of childhood acute lymphoblastic leukemia.
    Follin C; Thilén U; Osterberg K; Björk J; Erfurth EM
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3726-35. PubMed ID: 20484480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia.
    Follin C; Thilén U; Ahrén B; Erfurth EM
    J Clin Endocrinol Metab; 2006 May; 91(5):1872-5. PubMed ID: 16522695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood.
    Link K; Moëll C; Garwicz S; Cavallin-Ståhl E; Björk J; Thilén U; Ahrén B; Erfurth EM
    J Clin Endocrinol Metab; 2004 Oct; 89(10):5003-12. PubMed ID: 15472198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
    Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuing long-term GH replacement therapy--a randomized, placebo-controlled crossover trial in adult GH deficiency.
    Filipsson Nyström H; Barbosa EJ; Nilsson AG; Norrman LL; Ragnarsson O; Johannsson G
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3185-95. PubMed ID: 22791760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GH-deficient survivors of childhood cancer: GH replacement during adult life.
    Murray RD; Darzy KH; Gleeson HK; Shalet SM
    J Clin Endocrinol Metab; 2002 Jan; 87(1):129-35. PubMed ID: 11788635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult survivors of childhood acute lymphoblastic leukaemia with GH deficiency have normal self-rated quality of life but impaired neuropsychological performance 20 years after cranial irradiation.
    Link K; Moëll C; Osterberg K; Persson R; Ørbaek P; Garwicz S; Cavallin-Ståhl E; Erfurth EM
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):617-25. PubMed ID: 17054463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
    Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
    Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Left ventricular mass and function in growth hormone deficient children and adolescents before and after one year of recombinant human growth hormone (GH) replacement therapy].
    Szczepańska Kostro J; Tołwińska J; Urban M; Głowińska B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):75-80. PubMed ID: 15504309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: a phase III multicenter, double-blind, randomized two-year trial.
    Mauras N; Pescovitz OH; Allada V; Messig M; Wajnrajch MP; Lippe B;
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3946-55. PubMed ID: 15855257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of growth hormone therapy on bone mass, metabolic balance, and well-being in young adult survivors of childhood acute lymphoblastic leukemia.
    van den Heijkant S; Hoorweg-Nijman G; Huisman J; Drent M; van der Pal H; Kaspers GJ; Delemarre-van de Waal H
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):e231-8. PubMed ID: 21792029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic profile in growth hormone-deficient (GHD) adults after long-term recombinant human growth hormone (rhGH) therapy.
    Claessen KM; Appelman-Dijkstra NM; Adoptie DM; Roelfsema F; Smit JW; Biermasz NR; Pereira AM
    J Clin Endocrinol Metab; 2013 Jan; 98(1):352-61. PubMed ID: 23162104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of cardiac performance and cardiovascular risk factors in children with GH deficiency after two years of GH replacement therapy: an observational, open, prospective, case-control study.
    Salerno M; Esposito V; Farina V; Radetti G; Umbaldo A; Capalbo D; Spinelli L; Muzzica S; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1288-95. PubMed ID: 16403823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children.
    Johannsson G; Albertsson-Wikland K; Bengtsson BA
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4516-24. PubMed ID: 10599711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency.
    Colao A; di Somma C; Cuocolo A; Spinelli L; Tedesco N; Pivonello R; Bonaduce D; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 2001 May; 86(5):1874-81. PubMed ID: 11344175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study.
    Colao A; di Somma C; Pivonello R; Cuocolo A; Spinelli L; Bonaduce D; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1088-93. PubMed ID: 11889170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline characteristics and the effects of two years of growth hormone (GH) replacement therapy in adults with GH deficiency previously treated for acromegaly.
    Norrman LL; Johannsson G; Sunnerhagen KS; Svensson J
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2531-8. PubMed ID: 18397981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy.
    Salerno M; Esposito V; Spinelli L; Di Somma C; Farina V; Muzzica S; de Horatio LT; Lombardi G; Colao A
    Clin Endocrinol (Oxf); 2004 May; 60(5):630-6. PubMed ID: 15104568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survivors of childhood acute lymphoblastic leukaemia, with radiation-induced GH deficiency, exhibit hyperleptinaemia and impaired insulin sensitivity, unaffected by 12 months of GH treatment.
    Bülow B; Link K; Ahrén B; Nilsson AS; Erfurth EM
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):683-91. PubMed ID: 15579181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.